These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 2013778)

  • 1. Evidence against leukotrienes as mediators of brain edema.
    Unterberg A; Schmidt W; Wahl M; Ellis EF; Marmarou A; Baethmann A
    J Neurosurg; 1991 May; 74(5):773-80. PubMed ID: 2013778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of leukotrienes as mediator compounds in brain edema.
    Unterberg A; Schmidt W; Wahl M; Baethmann A
    Adv Neurol; 1990; 52():211-4. PubMed ID: 2118715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of infusion-induced brain edema by mediator compounds.
    Unterberg A; Polk T; Ellis E; Marmarou A
    Adv Neurol; 1990; 52():355-8. PubMed ID: 2168664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of arachidonic acid metabolites on development of ischemic cerebral edema in rat middle cerebral artery occlusion].
    Suzuka T; Mabe H; Ito E
    No To Shinkei; 1994 Jan; 46(1):39-45. PubMed ID: 8136198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal profiles of cerebrospinal fluid leukotrienes, brain edema and inflammatory response following experimental brain injury.
    Schuhmann MU; Mokhtarzadeh M; Stichtenoth DO; Skardelly M; Klinge PM; Gutzki FM; Samii M; Brinker T
    Neurol Res; 2003 Jul; 25(5):481-91. PubMed ID: 12866196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the arachidonate lipoxygenase inhibitor BW755C on traumatic and peritumoural brain oedema.
    Ikeda Y; Long DM
    Acta Neurochir Suppl (Wien); 1990; 51():68-70. PubMed ID: 2128585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kallikrein-kinin system as mediator in vasogenic brain edema. Part 3: Inhibition of the kallikrein-kinin system in traumatic brain swelling.
    Unterberg A; Dautermann C; Baethmann A; Müller-Esterl W
    J Neurosurg; 1986 Feb; 64(2):269-76. PubMed ID: 2418176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of 5-lipoxygenase inhibition on blood-brain barrier permeability in experimental brain tumors.
    Baba T; Chio CC; Black KL
    J Neurosurg; 1992 Sep; 77(3):403-6. PubMed ID: 1354721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of postischemic brain hypoperfusion and reperfusion injury by the cyclooxygenase-lipoxygenase inhibitor BW755C.
    Chen J; Weinstein PR; Graham SH
    J Neurosurg; 1995 Jul; 83(1):99-104. PubMed ID: 7782858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective blood-tumor barrier disruption by leukotrienes.
    Chio CC; Baba T; Black KL
    J Neurosurg; 1992 Sep; 77(3):407-10. PubMed ID: 1506887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permeability and vasomotor response of cerebral vessels during exposure to arachidonic acid.
    Unterberg A; Wahl M; Hammersen F; Baethmann A
    Acta Neuropathol; 1987; 73(3):209-19. PubMed ID: 2441558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracarotid infusion of leukotriene C4 selectively increases blood-brain barrier permeability after focal ischemia in rats.
    Baba T; Black KL; Ikezaki K; Chen KN; Becker DP
    J Cereb Blood Flow Metab; 1991 Jul; 11(4):638-43. PubMed ID: 1675639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mediators of vascular and parenchymal mechanisms in secondary brain damage.
    Wahl M; Schilling L; Unterberg A; Baethmann A
    Acta Neurochir Suppl (Wien); 1993; 57():64-72. PubMed ID: 7678480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of glutamate and of free fatty acids in vasogenic brain edema.
    Baethmann A; Maier-Hauff K; Schürer L; Lange M; Guggenbichler C; Vogt W; Jacob K; Kempski O
    J Neurosurg; 1989 Apr; 70(4):578-91. PubMed ID: 2564431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of parenteral nutrition on cold-induced vasogenic edema in cats.
    Waters DC; Hoff JT; Black KL
    J Neurosurg; 1986 Mar; 64(3):460-5. PubMed ID: 3081694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of arachidonic acid to the aetiology and pathophysiology of focal brain oedema; studies using an infusion oedema model.
    Whittle IR; Piper IR; Miller JD
    Acta Neurochir (Wien); 1991; 113(1-2):57-68. PubMed ID: 1665951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous glutamate enhances edema formation after a freezing lesion.
    Kempski O; von Andrian U; Schürer L; Baethmann A
    Adv Neurol; 1990; 52():219-23. PubMed ID: 1975714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A mechanism of development and resolution of vasogenic brain edema].
    Tsuyumu M; Hiratsuka H; Inaba Y; Ito U; Reulen HJ
    No Shinkei Geka; 1986 Mar; 14(3 Suppl):287-94. PubMed ID: 3703127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukotrienes increase blood-brain barrier permeability following intraparenchymal injections in rats.
    Black KL; Hoff JT
    Ann Neurol; 1985 Sep; 18(3):349-51. PubMed ID: 2996417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Leukotriene synthesis by gastrointestinal tissue and its pharmacologic modification].
    Peskar BM; Kozuschek W; Morgenroth K; Hoppe U; Dreyling KW; Peskar BA
    Wien Klin Wochenschr; 1986 Feb; 98(4):98-104. PubMed ID: 3010577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.